Patients

Get nanotech-based
wound care today

Choosing the right treatment can be frustrating for medical practitioners as most wound care systems in the market are not designed to address the complexities of different wound types.

Rapid Nexus simplifies the wound treatment with Hemastyl Rx® Wound dressing, a nanoparticle formulation that treats wounds of all types, including severe ones that have previously been non-responsive to standard products and treatment.

Compared with existing chronic wound treatments, patients with co-morbidities treated with Hemastyl Rx® Wound dressing formulation enjoy a more effective treatment, reducing hospitalizations which often lead to amputations.

How Rapid Nexus wound healing system works

A nanotechnology wound gel dressing formulation that has shown to be effective in chronic wound healing of non-healing and hard to heal wounds. It has shown to promote self-debridement and its nanoparticle composition of silver plus + (a proprietary formulation consisting of 3 varieties of nanoparticles), naturally reduce bacterial bioburden.

A therapeutic heating device equipped with light-emitting diodes (LEDs) that increase the local blood circulation in order to accelerate the body’s reaction to Hemastyl Rx®. Therapeutic Gen-Ray® not only increases local blood circulation to speed up healing, it also relieves minor pain and stiffness in the treatment area.

The therapeutic heating properties of Gen-Ray® work best with Derma Light Tape which covers the wound securely.

Tissue Massager helps the healthcare professional with the massage of Hemastyl Rx® onto a wound's surrounding tissue.

Meanwhile, our Derma Air-Flo Compression Tape helps the Hemastyl Rx® Moist wound dressing set in for proper absorption.

A simplified approach

Rapid Nexus simplifies local wound care with a wound healing system that addresses the complicated needs of wound patients. Hemastyl-R® is a self-debriding dressing that maintains a proper moist wound healing environment, controls bacterial bioburden within the gel wound dressing and contains hyaluronic acid which donates moisture to the cells, connects fibrin to build skin matrix effectively.

Hemastyl-R® Wound dressing formulation is a breakthrough technology that effectively manages severe wounds and diminishes the need for additional surgical intervention for some patients. We have simplified the treatment method to help physicians aid more patients and save more lives in the process.

Our Rapid Nexus home kits are designed to allow doctors to treat patients via telemedicine.

Why Hemastyl-R® Wound dressing formulation is best for your patient

Is effective in older (over 65 yrs old) chronic wound patients with co-morbidities whose chronic wounds are not responsive to any other wound care solutions.
Based on patient studies, Hemastyl-R® Wound dressing formulation repaired complex non-healing leg ulcers, which have had a 0% success rate of wound healing progress using already cleared and approved devices.
Hemastyl-R® Wound dressing formulation is an effective formulation for many varieties of wounds and simplifies treatment.
Compared with the Hemastyl-R® Wound dressing formulation, other wound treatment alternatives have had a very low success rate in complex wound closure with co-morbidities. This low success rate often leads to repetitive hospitalizations or death.

Study Cases

Examples of severe lower extremity non-healing chronic wounds before and after treatment with the Hemastyl Rx® with the Hemastyl-R® Wound gel dressing composition. The wounds include vascular and diabetic ulcers with severe peripheral blood circulation dysfunction and/or severe necrosis.